BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8982717)

  • 1. The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal.
    Putzke J; Spanagel R; Tölle TR; Zieglgänsberger W
    Eur J Pharmacol; 1996 Dec; 317(1):39-48. PubMed ID: 8982717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acamprosate decreases the hypermotility during repeated ethanol withdrawal.
    Dahchour A; De Witte P
    Alcohol; 1999 May; 18(1):77-81. PubMed ID: 10386669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze.
    Cole JC; Littleton JM; Little HJ
    Psychopharmacology (Berl); 2000 Jan; 147(4):403-11. PubMed ID: 10672634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
    Kratzer U; Schmidt WJ
    Neurosci Lett; 1998 Aug; 252(1):53-6. PubMed ID: 9756357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.
    Heyser CJ; Schulteis G; Durbin P; Koob GF
    Neuropsychopharmacology; 1998 Feb; 18(2):125-33. PubMed ID: 9430136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Bochenski M
    Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat.
    Spanagel R; Putzke J; Stefferl A; Schöbitz B; Zieglgänsberger W
    Eur J Pharmacol; 1996 Jun; 305(1-3):45-50. PubMed ID: 8813530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of age at drinking onset on the alcohol deprivation effect and stress-induced drinking in female rats.
    Füllgrabe MW; Vengeliene V; Spanagel R
    Pharmacol Biochem Behav; 2007 Feb; 86(2):320-6. PubMed ID: 17098280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acamprosate, MK-801, and ifenprodil inhibit neurotoxicity and calcium entry induced by ethanol withdrawal in organotypic slice cultures from neonatal rat hippocampus.
    Mayer S; Harris BR; Gibson DA; Blanchard JA; Prendergast MA; Holley RC; Littleton J
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1468-78. PubMed ID: 12394279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods.
    Dahchour A; De Witte P
    Alcohol Clin Exp Res; 2003 Mar; 27(3):465-70. PubMed ID: 12658112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats.
    Dahchour A; Lallemand F; Ward RJ; De Witte P
    Eur J Pharmacol; 2005 Sep; 520(1-3):51-8. PubMed ID: 16135364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons.
    Popp RL; Lovinger DM
    Eur J Pharmacol; 2000 Apr; 394(2-3):221-31. PubMed ID: 10771287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate.
    Dahchour A; De Witte P
    Prog Neurobiol; 2000 Mar; 60(4):343-62. PubMed ID: 10670704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.
    Lidö HH; Marston H; Ericson M; Söderpalm B
    Addict Biol; 2012 Sep; 17(5):897-907. PubMed ID: 21955180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats.
    Dahchour A; De Witte P; Bolo N; Nédélec JF; Muzet M; Durbin P; Macher JP
    Psychiatry Res; 1998 May; 82(2):107-14. PubMed ID: 9754453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release.
    Olive MF; Nannini MA; Ou CJ; Koenig HN; Hodge CW
    Eur J Pharmacol; 2002 Feb; 437(1-2):55-61. PubMed ID: 11864639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat.
    Spanagel R; Hölter SM; Allingham K; Landgraf R; Zieglgänsberger W
    Eur J Pharmacol; 1996 Jun; 305(1-3):39-44. PubMed ID: 8813529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the combined administration of ethanol and acamprosate on rabbit EEG.
    Pietrzak B; Czarnecka E
    Pharmacol Rep; 2005; 57(1):61-9. PubMed ID: 15849378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.